BMC Microbiology (Jul 2001)

Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae

  • Moreillon Philippe,
  • Que Yok-Ai,
  • Cottagnoud Marianne,
  • Entenza Jose M,
  • Cottagnoud Philippe,
  • Täuber Martin G

DOI
https://doi.org/10.1186/1471-2180-1-9
Journal volume & issue
Vol. 1, no. 1
p. 9

Abstract

Read online

Abstract Background The continuous spread of penicillin-resistant pneumococci represents a permanent threat in the treatment of pneumococcal infections, especially when strains show additional resistance to quinolones. The main objective of this study was to determine a treatment modality impeding the emergence of quinolone resistance. Results Exposure of a penicillin-resistant pneumococcus to increasing concentrations of trovafloxacin or ciprofloxacin selected for mutants resistant to these drugs. In the presence of sub-inhibitory concentrations of vancomycin, development of trovafloxacin-resistance and high-level ciprofloxacin-resistance were prevented. Conclusions Considering the risk of quinolone-resistance in pneumococci, the observation might be of clinical importance.